As U.S. equity valuations remain elevated, investors are increasingly looking abroad for diversification and relative value. FENI and VXUS are two of the most frequently discussed vehicles for international exposure, yet they solve different problems. VXUS is a broad, low-cost index fund covering virtually the entire non-U.S. investable market, while FENI is a concentrated, actively managed fund targeting developed markets with a quantitative, factor-based approach. Comparing them highlights the trade-off between maximum diversification at minimal cost and a more selective, research-driven strategy. This ETF comparison examines structure, sector exposure, cost, and relative positioning to help investors determine which approach aligns with their goals. I also checked this using Tickeron’s AI Screener to see how the funds compare on key metrics.
FENI is an actively managed ETF launched in December 2007 by Fidelity. The fund invests at least 80% of its assets in stocks drawn from the MSCI EAFE Index, a market-capitalization-weighted benchmark covering developed markets in Europe, Australasia, and the Far East, while excluding the United States and Canada. Rather than replicating the index, Fidelity applies a quantitative, research-driven process that emphasizes factors such as valuation, growth, and quality.
The portfolio holds roughly 440 securities, with a large-cap bias. Top positions include ASML Holding, Roche, Nestlé, Siemens, Tokyo Electron, Novartis, and UBS. Sector allocation leans toward financials (about 24–26%), industrials (about 20–23%), and technology (about 11–12%), with healthcare and consumer cyclicals rounding out the mix. Geographically, Japan, the Eurozone, and the United Kingdom dominate exposure. The fund carries a 0.28% net expense ratio, relatively low for an active strategy but higher than passive peers. With roughly $11 billion in assets under management (AUM), FENI offers solid but more modest liquidity than index giants.
VXUS is a passive index ETF launched in January 2011 by Vanguard. It seeks to track the FTSE Global All Cap ex US Index, a float-adjusted, market-capitalization-weighted benchmark measuring stock performance across developed and emerging markets outside the United States, spanning large-, mid-, and small-cap companies. The fund holds roughly 8,800 securities, covering about 99% of global market capitalization outside the U.S.
Top holdings include Taiwan Semiconductor Manufacturing (TSMC), Samsung Electronics, SK hynix, ASML, Tencent, HSBC, Roche, Shell, Royal Bank of Canada, and Novartis. Sector allocation is led by financial services (about 23%), technology (about 21%), and industrials (about 15%), with meaningful weight in basic materials and healthcare. Emerging markets represent roughly 25–30% of the portfolio, with notable exposure to China, Taiwan, South Korea, and India. The fund's 0.05% expense ratio makes it among the cheapest ways to access international equities, and its substantial scale—one of the largest international ETFs in the market—supports strong liquidity and tight trading spreads.
Both funds operate within the same broad macro environment: a multi-year debate over whether international equities can narrow the performance gap with richly valued U.S. stocks. A weakening U.S. dollar, improving earnings in Japan and Europe, and ongoing corporate governance reforms have supported renewed flows into non-U.S. equities in recent market cycles. At the same time, sector composition creates divergent risk profiles. VXUS's heavier technology exposure ties it closely to the global semiconductor cycle and Asian hardware demand, while FENI's financial and industrial tilt makes it more sensitive to European and Japanese banking conditions, credit cycles, and capital-goods activity. Currency movements, central-bank policy divergence, and geopolitical developments—particularly in Europe and Asia—remain key catalysts and risks for both funds.
In recent months, both funds have generally benefited from improving international sentiment, though their performance drivers differ. VXUS's emerging-market and technology exposure has amplified returns during periods of Asian tech strength and U.S. dollar softness, while FENI's defensive, factor-tilted portfolio has historically shown lower volatility relative to broad benchmarks. The two funds' divergent sector exposure—VXUS's heavier technology versus FENI's financial and industrial concentration—means they frequently respond differently to interest-rate expectations, earnings cycles, and commodity trends. VXUS's near-complete market coverage reduces single-stock and single-country risk, whereas FENI's selectivity introduces greater relative risk but also the potential for factor-driven outperformance. On cost efficiency and breadth, VXUS holds a clear structural edge; on differentiated positioning, FENI offers a more targeted active approach. From what I see, running a quick scan with Tickeron’s AI Pattern Search Engine helped confirm how these sector differences play out over time.
In my analysis process, I often turn to Tickeron’s AI Screener to quickly filter and compare ETFs on factors like holdings breadth, expense ratios, and sector tilts. It streamlines spotting how options like these align with different investor needs without manual number-crunching. This tool has become a regular part of reviewing international allocations for clients and my own portfolio.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VXUS advanced for three days, in 280 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
VXUS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VXUS crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VXUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for VXUS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend